1.05
price down icon1.87%   -0.02
after-market Handel nachbörslich: 1.06 0.01 +0.95%
loading

Finanzdaten der Rapt Therapeutics Inc-Aktie (RAPT)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
-
- - - -
Operating Expenses
2.10%
32.52
33.22 33.92 28.36 31.56
Depreciation and Amortization
2.79%
0.314
0.323 0.30 0.30 0.299
Operating Income/Loss
2.10%
-32.52
-33.22 -33.92 -28.36 -31.56
Nonoperating Income/Loss
14.69%
1.997
2.341 2.548 3.084 2.291
Income/Loss From Continuing Operations Before Tax
1.15%
-30.52
-30.88 -31.37 -25.28 -29.27
Income/Loss From Continuing Operations After Tax
1.15%
-30.52
-30.88 -31.37 -25.28 -29.27
Net Income/Loss
1.15%
-30.52
-30.88 -31.37 -25.28 -29.27
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
250.91K%
38.63
0.0154 38.36 38.33 38.28
Diluted Average Shares
250.91K%
38.63
0.0154 38.36 38.33 38.28
Basic Earnings Per Share
2.47%
-0.79
-0.81 -0.82 -0.66 -0.76
Diluted Earnings Per Share
2.47%
-0.79
-0.81 -0.82 -0.66 -0.76
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$70.39
price down icon 0.93%
$18.42
price down icon 1.07%
$38.25
price up icon 3.55%
$367.36
price up icon 0.83%
$194.56
price up icon 0.15%
$108.23
price up icon 5.96%
Kapitalisierung:     |  Volumen (24h):